Chandran Nadarajan/LinkedIn
Jun 7, 2026, 06:57
Chandran Nadarajan: Targeted Endovascular Thrombolysis Offers Organ-Saving Benefits in Vascular Occlusions
Chandran Nadarajan, Clinical and Interventional Radiologist at Gleneagles Hospital Kota Kinabalu, shared a post on LinkedIn:
“Catheter-Directed Thrombolysis (CDT)
A minimally invasive, image-guided treatment designed to dissolve dangerous blood clots and restore healthy blood flow.
CDT delivers clot-busting medication directly into the clot, helping to:
- Restore circulation quickly
- Preserve limbs and healthy tissue
- Reduce complications
- Minimize damage to surrounding blood vessels
- Shorten hospital stay and recovery time
This treatment may be suitable for conditions such as:
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Acute Limb Ischemia
- Thrombosed Dialysis Access
- May-Thurner Syndrome
For consultation and further information:
Dr. Chandran Nadarajan
Consultant Clinical and Interventional Radiologist
Gleneagles Hospital, Kota Kinabalu
Clinic (DL): +6 088-518 888
WhatsApp: +6 012 477 5257.”
Stay updated with Hemostasis Today.
-
Jun 7, 2026, 05:50Sayan Koley: Lupus Anticoagulant – A Key Marker in Thrombosis Risk Assessment
-
Jun 7, 2026, 05:45Nicolas Hubacz: Watching a Heart Build Its Network
-
Jun 7, 2026, 05:40New Evidence Highlights the Urgent Need for Gender-Inclusive Bleeding Disorders Research – EHC
-
Jun 7, 2026, 03:15Shirley D’Sa: What Comes After BTK Inhibitors in Waldenström Macroglobulinaemia?
-
Jun 6, 2026, 23:30Yazan Abou-Ismail: Insights on A Snail-Derived Potential Anticoagulant with Possibly Improved Bleeding Profile
-
Jun 6, 2026, 18:40Igor Carvalho de Oliveira: The Hidden Genetic Risk Behind Early Heart Attacks and Strokes
-
Jun 6, 2026, 17:39Kalyan Roy: Immunomodulation after Blood Transfusion
-
Jun 6, 2026, 17:37Intissar Haddiya: Can Low-Dose Rivaroxaban Improve Cardiovascular Outcomes in Patients with Advanced CKD?
-
Jun 6, 2026, 17:34Stanley Anokye: From Microcytes and Macrocytes to Target Cells